TipRanks
Go Ultimate55% OFF

Ligand Pharma (LGDN) Cash flow

Ligand Pharma Cash Flow

DE:LGDN's free cash flow for Q3 2026 was $-27.73M. For the 2026 fiscal year, DE:LGDN's free cash flow was decreased by $-142.00K and operating cash flow was $-27.59M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 49.36M$ 97.05M$ 49.58M$ 137.85M$ 78.80M
$ -377.32M$ -143.66M$ -11.68M$ 163.62M$ 30.52M
$ 428.22M$ 97.14M$ -59.95M$ -275.99M$ -137.76M
$ 174.93M$ 72.31M$ 22.95M$ 45.01M$ 19.52M
$ 48.91M$ 77.41M$ -4.27M$ 119.93M$ 70.04M

Currency in USD

Ligand Pharma Cash Flow

-750M-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing